Published in ACS Med Chem Lett on June 26, 2014
Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series. Proc Natl Acad Sci U S A (2005) 2.29
Synthetic analgesics: stereochemical considerations. J Pharm Pharmacol (1954) 1.92
A bivalent ligand (KDN-21) reveals spinal delta and kappa opioid receptors are organized as heterodimers that give rise to delta(1) and kappa(2) phenotypes. Selective targeting of delta-kappa heterodimers. J Med Chem (2004) 1.61
Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo. Arch Int Pharmacodyn Ther (1992) 1.51
Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at mu, delta, and kappa opioid receptors. J Med Chem (2006) 1.37
Pharmacological profiles of beta-funaltrexamine (beta-FNA) and beta-chlornaltrexamine (beta-CNA) on the mouse vas deferens preparation. Eur J Pharmacol (1982) 1.21
The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone. Eur J Pharmacol (1981) 1.16
Effects of beta-funaltrexamine (beta-FNA) on morphine dependence in rats and monkeys. Eur J Pharmacol (1986) 0.83
Effect of beta-funaltrexamine on opioid side-effects produced by morphine and U-50, 488H. J Pharm Pharmacol (1985) 0.83
Novel synthesis of a 1,3,5-trioxazatriquinane skeleton using a nitrogen clamp. Org Lett (2009) 0.82
Analgesics and their antagonists: some steric and chemical considerations. I. The dissociation constants of some tertiary amines and synthetic analgesics, the conformations of methadone-type compounds. J Pharm Pharmacol (1956) 0.82
Twin and triplet drugs in opioid research. Top Curr Chem (2011) 0.81
Discovery and pharmacological evaluation of a diphenethylamine derivative (HS665), a highly potent and selective κ opioid receptor agonist. J Med Chem (2012) 0.80
Synthesis of quinolinomorphinan-4-ol derivatives as δ opioid receptor agonists. Bioorg Med Chem (2011) 0.80
Syntheses of 4,6'-epoxymorphinan derivatives and their pharmacologies. Bioorg Med Chem (2008) 0.79
3D-pharmacophore identification for kappa-opioid agonists using ligand-based drug-design techniques. Top Curr Chem (2011) 0.78
Synthesis of novel triplet drugs with 1,3,5-trioxazatriquinane skeletons and their pharmacologies. 1: Synthesis of triplet drugs with morphinan skeletons. Bioorg Med Chem Lett (2011) 0.78
Synthesis of novel triplet drugs with 1,3,5-trioxazatriquinane skeletons and their pharmacologies. Part 2: Synthesis of novel triplet drugs with the epoxymethano structure (capped homotriplet). Bioorg Med Chem Lett (2011) 0.78
Identification of the three-dimensional pharmacophore of kappa-opioid receptor agonists. Bioorg Med Chem (2010) 0.78
Synthesis of novel triplet drugs with 1,3,5-trioxazatriquinane skeletons and their pharmacologies. 3: synthesis of novel triplet drugs with the bis(epoxymethano) or bis(dimethylepoxymethano) structure (double-capped triplet). Bioorg Med Chem Lett (2012) 0.77
Novel delta opioid receptor agonists with oxazatricyclodecane structure. ACS Med Chem Lett (2014) 0.75